John Jeffrey

A phase III randomized trial of BAY 12-9566 (tanomastat) as maintenance therapy in patients with advanced ovarian cancer responsive to primary surgery and paclitaxel/platinum containing chemotherapy: A National Cancer Institute of Canada Clinical Trials Group Study

Hal W. Hirte, Ignace Vergote, John Jeffrey et al. · Gynecologic Oncology · 2006 · 146 citations

National Cancer Institute, Surgical Oncology, Medicine +9

SOGC clinical guidelines. Hysterectomy.

Guylaine Lefebvre, Catherine Allaire, John Jeffrey et al. · PubMed · 2002 · 74 citations

SAFETY AND TOLERABILITY OF CYCLOSPORINE AND CYCLOSPORINE MICROEMULSION DURING 18 MONTHS OF FOLLOW-UP IN STABLE RENAL TRANSPLANT RECIPIENTS

Edward Cole, Paul Keown, David Landsberg et al. · Transplantation · 1998 · 68 citations

Studies of Digoxin Dosage, Kinetics and Serum Concentrations in Renal Failure and Review of the Literature

Henry Gault, John Jeffrey, Edward Chirito et al. · Nephron · 1976 · 48 citations

Renal Function, Medicine, Renal Failure +10

Phase II Study to Evaluate the Toxicity and Efficacy of Concurrent Cisplatin and Radiation Therapy in the Treatment of Patients with Locally Advanced Squamous Cell Carcinoma of the Cervix

R. Pearcey, Gavin Stuart, Grant D. MacLean et al. · Gynecologic Oncology · 1995 · 34 citations

Cervical Cancer Management, Cervical Cancer, Radiation Therapy +8